Weekly insulin shot plus skin sensor could simplify diabetes care
NCT ID NCT05823948
First seen Jan 11, 2026 · Last updated Jun 23, 2026 · Updated 24 times
Summary
This study tested a new approach for people with type 2 diabetes: a once-weekly insulin injection (insulin icodec) combined with a flash glucose monitor, a small sensor worn on the arm that tracks blood sugar continuously. The goal was to see if this combination helps control blood sugar levels over 26 weeks. The study involved 51 adults with type 2 diabetes who had never used insulin before. Participants injected insulin once a week and scanned the sensor four times daily using a study phone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AM Diabetes And Endocrinology
Bartlett, Tennessee, 38133, United States
-
Accellacare_NC
Wilmington, North Carolina, 28401, United States
-
Amarillo Medical Specialists
Amarillo, Texas, 79124, United States
-
Chrysalis Clinical Research
St. George, Utah, 84790, United States
-
Clinical Trials Research_Sacramento_0
Sacramento, California, 95821, United States
-
Clinical Trials of Texas Inc
San Antonio, Texas, 78229, United States
-
Desert Oasis Hlthcr Med Group
Palm Springs, California, 92262, United States
-
Diabetes & Endocrinology Asso
Canton, Ohio, 44718, United States
-
East West Med Res Inst
Honolulu, Hawaii, 96814, United States
-
Florida Inst For Clin Res LLC
Orlando, Florida, 32825, United States
-
Fmc Science, Llc
Lampasas, Texas, 76550, United States
-
International Diabetes Center
Minneapolis, Minnesota, 55416, United States
-
Metabolic Research Institute Inc
West Palm Beach, Florida, 33401, United States
-
Mills-Peninsula Hlth Services
San Mateo, California, 94401, United States
-
Northeast Clinical Research of San Antonio
San Antonio, Texas, 78233, United States
-
Northern Pines Hlth Ctr, PC
Buckley, Michigan, 49620, United States
-
Palm Research Center Inc-Vegas
Las Vegas, Nevada, 89148, United States
-
San Diego Family Care
San Diego, California, 92111, United States
-
UT Southwestern Med Cntr
Dallas, Texas, 75390-9302, United States
-
Velocity Clin Res, Dallas
Dallas, Texas, 75230, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
insulin icodec (once-weekly insulin injection)
What this could lead to
If successful, this could make managing type 2 diabetes easier with a once-weekly insulin shot and a simple sensor to track blood sugar.
What could go wrong
This is a small, completed Phase 3 trial with only 51 participants. Results may not apply to everyone, and insulin can cause low blood sugar or other side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.